In vitro Development of Controlled-Release Nanoniosomes for Improved Delivery and Anticancer Activity of Letrozole for Breast Cancer Treatment
Open accessThe DOI matches its Crossref record; 85 of the 86 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Introduction: Breast cancer is among the most prevalent mortal cancers in women worldwide. In the present study, an optimum formulation of letrozole, letrozole-loaded niosome, and empty niosome was developed, and the anticancer effect was assessed in in vitro MCF-7, MCF10A and MDA-MB-231 breast cancer cell lines. Materials and Methods: Various niosomal formulations of letrozole were fabricated through thin-film hydration method and characterized in terms of size, polydispersity index (PDI), morphology, entrapment efficiency (EE%), release kinetics, and stability. Optimized niosomal formulation of letrozole was achieved by response surface methodology (RSM). Antiproliferative activity and the mechanism were assessed by MTT assay, quantitative real-time PCR, and flow cytometry. Furthermore, cellular uptake of optimum formulation was evaluated by confocal electron microscopy. Results: The formulated letrozole had a spherical shape and showed a slow-release profile of the drug after 72 h. The size, PDI, and eEE% of nanoparticles showed higher stability at 4°C compared with 25°C. The drug release from niosomes was in accordance with Korsmeyer–Peppa’s kinetic model. Confocal microscopy revealed the localization of drug-loaded niosomes in the cancer cells. MTT assay revealed that all samples exhibited dose-dependent cytotoxicity against breast cancer cells. The IC 50 of mixed formulation of letrozole with letrozole-loaded niosome (L + L 3 ) is the lowest value among all prepared formulations. L+L 3 influenced the gene expression in the tested breast cancer cell lines by down-regulating the expression of Bcl 2 gene while up-regulating the expression of p53 and Bax genes. The flow cytometry results revealed that L + L 3 enhanced the apoptosis rate in both MCF-7 and MDA-MB-231 cell lines compared with the letrozole (L), letrozole-loaded niosome (L 3 ), and control sample. Conclusion: Results indicated that niosomes could be a promising drug carrier for the delivery of letrozole to breast cancer cells. Graphical Abstract: Keywords: breast cancer, niosome, letrozole, drug delivery system, anticancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures










Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Haseli, S., Pourmadadi, M., Samadi, A., Yazdian, F. A., Abdouss, M., Rashedi, H., & Nigjeh, M. N. (2022) · Biotechnology Progress · doi:10.1002/btpr.3280 · Cited by 83 · cited 1×
“Development of targeted drug delivery systems (DDSs) has received extensive attention.(12,13,14,15) The combination of medicine and nanotechnology has modified multifunctional nanocarriers that can be loaded with different drugs.”
BackgroundRetractedBray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109 · cited 1×
“Introduction Over the past decade a surge of breast cancer incidence was observed among the female population.(1,2) Most breast cancers are hormone-dependent and estrogen is a mediator hormone in progression and metastasis of tumor cells.”
BackgroundRe-epithelialization and immune cell behaviour in an ex vivo human skin model
Rakita, A., Nikolić, N., Mildner, M., Matiasek, J., & Elbe-Bürger, A. (2020) · Scientific Reports · doi:10.1038/s41598-019-56847-4 · Cited by 8,228
Mechanisms of solute release from porous hydrophilic polymers
Korsmeyer, R. W., Gurny, R., Doelker, E., Buri, P., & Peppas, N. A. (1983) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(83)90064-9 · Cited by 5,258 · cited 1×
“85) indicate that drug release is based on Fickian diffusion release.(65,66) More stability of the niosomes stored at 4 ± 2°C is possibly due to less mobility of bilayer at this temperature.”
BackgroundLive or let die: the cell's response to p53
Vousden, K. H., & Lu, X. (2002) · Nature Reviews Cancer · doi:10.1038/nrc864 · Cited by 3,192
Kinetic modeling on drug release from controlled drug delivery systems.
Dash, S., Murthy, P. N., Nath, L., & Chowdhury, P. (2010) · PubMed · Cited by 2,733
Endosomal escape pathways for delivery of biologicals
Varkouhi, A. K., Scholte, M., Storm, G., & Haisma, H. J. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.11.004 · Cited by 1,561 · cited 1×
“Polymeric nanoparticles penetrate into cancer cells, diffuse in the cytoplasm, and escape from endosomal degradation.(56,84,85) Another study revealed that nanoparticles of mesoporous silica could enter the cells and remain for a long time which is enough to allow the release of drug from formulation.”
BackgroundNonionic surfactant vesicular systems for effective drug delivery—an overview
Kumar, G. P., & Rajeshwarrao, P. (2011) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2011.09.002 · Cited by 644
Dombernowsky, P., Smith, I., Falkson, G., Leonard, R., Panasci, L., Bellmunt, J., Bezwoda, W., Gardin, G., Gudgeon, A., Morgan, M., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.2.453 · Cited by 638 · cited 1×
“5 mg/day dosage of letrozole was associated with poorer response rates in this study.(76) In another study which developed and evaluated the effect of letrozole-loaded hyaluronic acid/chitosan-coated poly(d,l-lactide-co-glycolide) nanoparticles on 24 female albino mice (20–25 g) it was found that 300 mg/kg of the letr…”
ResultVaseva, A. V., & Moll, U. M. (2009) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2008.10.005 · Cited by 618
Carbon Nanotubes: Smart Drug/Gene Delivery Carriers
Zare, H., Ahmadi, S., Ghasemi, A., Ghanbari, M., Rabiee, N., Bagherzadeh, M., Karimi, M., Webster, T. J., Hamblin, M. R., & Mostafavi, E. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s299448 · Cited by 452
Self-citationHemann, M. T., & Lowe, S. W. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401962 · Cited by 370
Surfactant Effects on Lipid-Based Vesicles Properties
Bnyan, R., Khan, I., Ehtezazi, T., Saleem, I., Gordon, S., O'Neill, F., & Roberts, M. (2018) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2018.01.005 · Cited by 315
In vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin
Pardakhty, A., Varshosaz, J., & Rouholamini, A. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.08.002 · Cited by 292
Agarwal, R., Katare, O. P., & Vyas, S. P. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00810-9 · Cited by 288 · cited 1×
“It seems that beyond a certain level of cholesterol, the bilayer structure may be altered and the amount of drug retained may be reduced.(51) Therefore, an optimal cholesterol ratio should be selected to achieve a high amount of drug loading and niosome stability.”
BackgroundThe discovery and mechanism of action of letrozole
Bhatnagar, A. S. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9696-3 · Cited by 219
Effect of cholesterol and temperature on the elastic properties of niosomal membranes
Nasseri, B. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.05.009 · Cited by 200 · cited 1×
“However, the C=C stretching peaks (at 1674 cm) peaks in cholesterol have vanished in the FT-IR spectra of the niosomes, further demonstrating the entrapment of cholesterol in the lipid bilayer shell and the formation of the niosomes.(42,43) Another important result was disappearing of the main characteristics peaks of…”
BackgroundWaddad, A. Y., Abbad, S., Yu, F., Munyendo, W. L. L., Wang, J., Lv, H., & Zhou, J. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.08.040 · Cited by 195 · cited 2×
“The uniform particles have a narrow size distribution and low tendency to aggregate.(55) Our results indicated that probe sonication decreases the particle size of the niosomes and results in a higher amount of cholesterol, which leads to lower entrapment efficiency of the drug.”
BackgroundResultBarani, M., Mirzaei, M., Torkzadeh‐Mahani, M., & Nematollahi, M. H. (2018) · DARU Journal of Pharmaceutical Sciences · doi:10.1007/s40199-018-0207-3 · Cited by 169
Chmiel, T., Mieszkowska, A., Kempińska-Kupczyk, D., Kot‐Wasik, A., Namieśnik, J., & Mazerska, Z. (2019) · Microchemical Journal · doi:10.1016/j.microc.2019.01.030 · Cited by 167
Tavano, L., Muzzalupo, R., Picci, N., & de Cindio, B. (2014) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2013.09.058 · Cited by 165 · cited 1×
“Moreover, electrostatic interactions between drug and surfactants are essential, mainly when the drug exists in an ionized form at physiologic pH.(59) The initial phase involves the almost accelerated release of letrozole and then followed by a more passive release phase.”
BackgroundGhafelehbashi, R., Akbarzadeh, I., Tavakkoli Yaraki, M., Lajevardi, A., Fatemizadeh, M., & Heidarpoor Saremi, L. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.118580 · Cited by 163 · cited 3×
“However, the C=C stretching peaks (at 1674 cm) peaks in cholesterol have vanished in the FT-IR spectra of the niosomes, further demonstrating the entrapment of cholesterol in the lipid bilayer shell and the formation of the niosomes.(42,43) Another important result was disappearing of the main characteristics peaks of…”
BackgroundResultSelf-citationDixon, J. M., Renshaw, L., Young, O., Murray, J., Macaskill, E. J., McHugh, M., Folkerd, E., Cameron, D. A., A'Hern, R. P., & Dowsett, M. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.9279 · Cited by 160
Dijkshoorn, A. B. C., van Stralen, H. E., Sloots, M., Schagen, S. B., Visser‐Meily, J. M. A., & Schepers, V. P. M. (2021) · Psycho-Oncology · doi:10.1002/pon.5623 · Cited by 159 · cited 1×
“Introduction Over the past decade a surge of breast cancer incidence was observed among the female population.(1,2) Most breast cancers are hormone-dependent and estrogen is a mediator hormone in progression and metastasis of tumor cells.”
BackgroundXia, X.-X., Wang, M., Lin, Y., Xu, Q., & Kaplan, D. L. (2014) · Biomacromolecules · doi:10.1021/bm4017594 · Cited by 153
Moghaddam, F. D., Akbarzadeh, I., Marzbankia, E., Farid, M., Khaledi, L., Reihani, A. H., Javidfar, M., & Mortazavi, P. (2021) · Cancer Nanotechnology · doi:10.1186/s12645-021-00085-9 · Cited by 150 · cited 2×
“Furthermore, Melittin-loaded niosome revealed a significant higher apoptosis rate and inhibited cell migration, invasion in cancer cell lines compared with the free melittin samples.(37) In this paper, attempts are made to indicate the efficacy of niosomal letrozole on breast tumor cells.”
BackgroundMethodSelf-citationTarghi, A. A., Moammeri, A., Jamshidifar, E., Abbaspour, K., Sadeghi, S., Lamakani, L., & Akbarzadeh, I. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.105116 · Cited by 149
Self-citationWould Colloidal Gold Nanocarriers Present An Effective Diagnosis Or Treatment For Ischemic Stroke?
Amani, H., Mostafavi, E., Alebouyeh, M. R., Arzaghi, H., Akbarzadeh, A., Pazoki–Toroudi, H., & Webster, T. J. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s210035 · Cited by 146
Self-citationZeng, X., Morgenstern, R., & Nyström, A. M. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.10.042 · Cited by 136 · cited 1×
“The intensity of the mixed color represents well co-localization and overlap of the ingredients.(44)”
BackgroundFabrication of letrozole formulation using chitosan nanoparticles through ionic gelation method
Gomathi, T., Sudha, P. N., Florence, J. A. K., Venkatesan, J., & Anil, S. (2017) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2017.01.147 · Cited by 136 · cited 1×
“Most breast cancers are hormone-dependent and estrogen is a mediator hormone in progression and metastasis of tumor cells.(3,4) Letrozole, as an oral non-steroidal aromatase, decreases estrogen levels by binding to heme ion of cytochrome P-450 that converts testosterone into small amounts of estrogen in postmenopausal…”
BackgroundDodeji, F. N., Almasi, A., Javidi, J., Haeri, A., & Dadashzadeh, S. (2018) · Europe PMC (PubMed Central) · Cited by 131
Mirzaie, A., Peirovi, N., Akbarzadeh, I., Moghtaderi, M., Heidari, F., Yeganeh, F. E., Noorbazargan, H., Mirzazadeh, S., & Bakhtiari, R. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.104231 · Cited by 124 · cited 1×
“Also, the decrease in EE% at high temperatures may be due to more fluidization of the lipid vesicles and drug leakage.(70,71) In addition to this, due to the Figure 9 (A) Cell cycle analysis of MCF-7 and (B) MDA-MB-231 cells treated by different formulations of niosomes by the same concentration of the drug.”
BackgroundSelf-citationMostafavi, E., Zarepour, A., Barabadi, H., Zarrabi, A., Truong, L. B., & Medina-Cruz, D. (2022) · Biotechnology Reports · doi:10.1016/j.btre.2022.e00714 · Cited by 120
Self-citationDastneshan, A., Rahiminezhad, S., Mezajin, M. N., Jevinani, H. N., Akbarzadeh, I., Abdihaji, M., Qahremani, R., Jahanbakhshi, M., Lalami, Z. A., Heydari, H., et al. (2022) · Chemical Engineering Journal · doi:10.1016/j.cej.2022.140544 · Cited by 120
Self-citationMoghassemi, S., Parnian, E., Hakamivala, A., Darzianiazizi, M., Vardanjani, M. M., Kashanian, S., Larijani, B. A., & Omidfar, K. (2014) · Materials Science and Engineering C · doi:10.1016/j.msec.2014.10.070 · Cited by 116 · cited 1×
“The polydispersity index illustrates the uniformity of particle size and is a criterion for the width of the size distribution.(54) The PDI value varies between 0 and 1, and the lower PDI value belongs to the more homogeneous suspension.”
BackgroundHow Advancing are Mesoporous Silica Nanoparticles? A Comprehensive Review of the Literature
Porrang, S., Davaran, S., Rahemi, N., Allahyari, S., & Mostafavi, E. (2022) · International Journal of Nanomedicine · doi:10.2147/ijn.s353349 · Cited by 114
Self-citationAgarwal, S., Mohamed, M. S., Raveendran, S., Rochani, A., Maekawa, T., & Kumar, D. S. (2018) · RSC Advances · doi:10.1039/c8ra06362a · Cited by 108 · cited 2×
“The smaller size of the 80-span niosomes may be attributed to the length of the hydrophobic chain of this surfactant and the more hydrophilic-hydrophobic interaction between the encapsulated letrozole, cholesterol, DCP, and the hydrophobic chain of the surfactant.(41) The prepared niosomes with a lipid-to-drug ratio o…”
BackgroundAkbarzadeh, I., Yaraki, M. T., Bourbour, M., Noorbazargan, H., Lajevardi, A., Shilsar, S. M. S., Heidari, F., & Mousavian, S. M. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.101715 · Cited by 94
Self-citationCaffeine-Loaded Niosomes: Characterization and in Vitro Release Studies
Khazaeli, P., Pardakhty, A., & Shoorabi, H. (2007) · Drug Delivery · doi:10.1080/10717540701603597 · Cited by 93
Ashrafizadeh, M., Saebfar, H., Gholami, M. H., Hushmandi, K., Zabolian, A., Bikarannejad, P., Hashemi, M., Daneshi, S., Mirzaei, S., Sharifi, E., et al. (2022) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2022.2041598 · Cited by 93
Self-citationImproved oral delivery of valsartan from maltodextrin based proniosome powders
Gurrapu, A., Jukanti, R., Bobbala, S. R., Kanuganti, S., & Jeevana, J. B. (2011) · Advanced Powder Technology · doi:10.1016/j.apt.2011.06.005 · Cited by 92 · cited 1×
“These findings were in agreement with previous reports.(49,50) It seems that beyond a certain level of cholesterol, the bilayer structure may be altered and the amount of drug retained may be reduced.”
ResultMansoori-Kermani, A., Khalighi, S., Akbarzadeh, I., Ranjbar-Niavol, F., Motasadizadeh, H., Mahdieh, A., Jahed, V., Abdinezhad, M., Rahbariasr, N., Hosseini, M., et al. (2022) · Materials Today Bio · doi:10.1016/j.mtbio.2022.100349 · Cited by 92
Self-citationZhang, Y., Zhu, C., Zhang, Z., Zhao, J., Yuan, Y., & Wang, S. (2021) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2021.112025 · Cited by 91 · cited 1×
“Functional nanoparticles and photosensitizers have been encapsulated to maintain their appropriate concentration in the tumor section.(28) Chitosan/polyaniline/laponite hydrogels showed a high biocompatibility and the cell viability which provide a new reference for the tumor therapy and tissue regeneration.”
BackgroundStatins, Bcl-2, and Apoptosis: Cell Death or Cell Protection?
Wood, W. G., Igbavboa, U., Muller, W. E., & Eckert, G. P. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8496-5 · Cited by 89
Formulation and Characterization of Bovine Serum Albumin-Loaded Niosome
Moghassemi, S., Hadjizadeh, A., & Omidfar, K. (2016) · AAPS PharmSciTech · doi:10.1208/s12249-016-0487-1 · Cited by 83 · cited 1×
“These findings were in agreement with previous reports.(49,50) It seems that beyond a certain level of cholesterol, the bilayer structure may be altered and the amount of drug retained may be reduced.”
ResultSoltantabar, P., Calubaquib, E. L., Mostafavi, E., Biewer, M. C., & Stefan, M. C. (2020) · Biomacromolecules · doi:10.1021/acs.biomac.9b01742 · Cited by 83
Self-citationShad, P. M., Karizi, S. Z., Javan, R. S., Mirzaie, A., Noorbazargan, H., Akbarzadeh, I., & Rezaie, H. (2019) · Toxicology in Vitro · doi:10.1016/j.tiv.2019.104756 · Cited by 80 · cited 2×
“Preparation of Letrozole-Loaded Niosomes Letrozole-loaded niosomes were formulated by the thin-film hydration method.(15,38) The lipid:drug mixture was prepared in different molar ratios of 10:1 and 20:1.”
BackgroundMethodSelf-citationApproval summary: letrozole in the treatment of postmenopausal women with advanced breast cancer.
Cohen, M. H., Johnson, J. R., Li, N., Chen, G., & Pazdur, R. (2002) · PubMed · Cited by 79
Formulation and In Vivo Evaluation of Niosome-Encapsulated Daunorubicin Hydrochloride
Balasubramaniam, A., Kumar, V. A., & Pillai, K. S. (2002) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-120015351 · Cited by 78
Bazzazan, S., Moeinabadi‐Bidgoli, K., Lalami, Z. A., Bazzazan, S., Mehrarya, M., Yeganeh, F. E., Hejabi, F., Akbarzadeh, I., Noorbazargan, H., Jahanbakhshi, M., et al. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.104009 · Cited by 74
Self-citationMoghtaderi, M., Mirzaie, A., Zabet, N., Moammeri, A., Mansoori-Kermani, A., Akbarzadeh, I., Yeganeh, F. E., Chitgarzadeh, A., Kashtali, A. B., & Ren, Q. (2021) · Nanomaterials · doi:10.3390/nano11061573 · Cited by 73
Self-citationZhang, L., He, G., Yang, Y. L., Zhang, Y., Li, X., & Wang, S. (2022) · Biomolecules · doi:10.3390/biom12081089 · Cited by 73
Smart multifunctional nanoparticles in nanomedicine
Şeleci, M., Seleci, D. A., Joncyzk, R., Stahl, F., Blume, C. A., & Scheper, T. H. (2016) · BioNanoMaterials · doi:10.1515/bnm-2015-0030 · Cited by 72
Costanzo, M., Carton, F., Marengo, A., Berlier, G., Stella, B., Arpicco, S., & Malatesta, M. (2016) · European Journal of Histochemistry · doi:10.4081/ejh.2016.2640 · Cited by 71 · cited 1×
“Polymeric nanoparticles penetrate into cancer cells, diffuse in the cytoplasm, and escape from endosomal degradation.(56,84,85) Another study revealed that nanoparticles of mesoporous silica could enter the cells and remain for a long time which is enough to allow the release of drug from formulation.”
BackgroundKarimifard, S., Rezaei, N., Jamshidifar, E., Langeroodi, S. M. F., Abdihaji, M., Mansouri, A., Hosseini, M., Ahmadkhani, N., Rahmati, Z., Heydari, M., et al. (2022) · ACS Applied Nano Materials · doi:10.1021/acsanm.2c00861 · Cited by 71 · cited 1×
“However, DLS measures the hydrodynamic diameter that includes core plus any molecule attached or adsorbed on the surface, including ions and water molecules.(52,57,58) The rate of drug release depends on the composition and fluidity of the bilayer membrane.”
BackgroundSelf-citationTrunet, P. F. (1993) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.77.2.319 · Cited by 69 · cited 2×
“5 mg suppress estrogens to below the limit of detection.(74) In a study on 713 postmenopausal women with advanced breast cancer previously treated with an anti-estrogen, the effect of letrozole (2.”
BackgroundHedayati, M., Targhi, A. A., Shamsi, F., Heidari, F., Moghaddam, Z. S., Mirzaie, A., Behdad, R., Moghtaderi, M., & Akbarzadeh, I. (2020) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.37086 · Cited by 67 · cited 2×
“More stability of the niosomes stored at 4 ± 2°C is possibly due to less mobility of bilayer at this temperature.(27,42,67) Increasing the size of the vesicle during storage may be related to its fusion(68) or aggregation.”
BackgroundSelf-citationCarbon-based nanomaterials in gene therapy
Mostafavi, E., & Zare, H. (2022) · OpenNano · doi:10.1016/j.onano.2022.100062 · Cited by 64
Self-citationFolate Conjugated Hybrid Nanocarrier for Targeted Letrozole Delivery in Breast Cancer Treatment
Azandaryani, A. H., Kashanian, S., & Derakhshandeh, K. (2017) · Pharmaceutical Research · doi:10.1007/s11095-017-2260-x · Cited by 63 · cited 1×
“hypercholesterolemia, and carcinogenic failure.(8) Accordingly, the recommended dose of letrozole is 2.”
BackgroundYüksel, N., Bayındır, Z. S., Aksakal, E., & Ozcelikay, A. T. (2015) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2015.10.019 · Cited by 60 · cited 1×
“Aqueous solubility and oral bioavailability of niosomal Candesartan cilexetil, a commercially marketed compound with low bioavailability (15%), was significantly enhanced.(34) In a study, PEGylated niosomal vincristine showed potent in vitro toxicity in B-cell lymphoma cancer cells.”
BackgroundGhadi, Z. S., & Ebrahimnejad, P. (2019) · Journal of Microencapsulation · doi:10.1080/02652048.2019.1617360 · Cited by 60 · cited 1×
“Another study revealed that nanoparticles of mesoporous silica could enter the cells and remain for a long time which is enough to allow the release of drug from formulation.(86) TAT modification of liposome enhances drug delivery in the brain and especially glioma tissues.”
BackgroundJamshidifar, E., Yeganeh, F. E., Shayan, M., Yaraki, M. T., Bourbour, M., Moammeri, A., Akbarzadeh, I., Noorbazargan, H., & Hossein‐Khannazer, N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22157948 · Cited by 57
Self-citationWang, S., Yang, Y., Wu, H., Li, J., Xie, P., Xu, F., Zhou, L., Zhao, J., & Chen, H. (2021) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2021.12.126 · Cited by 57 · cited 1×
“Polydopamine decorated mesoporous silica nanoparticles showed a significant heat to kill colorectal cancer cells.(30) Niosomes as nonionic surfactants have been widely studied due to their advantages including biodegradability, biocompatibility, low immunogenicity, long shelf life, high stability, and allow drug deliv…”
BackgroundAmale, F. R., Ferdowsian, S., Hajrasouliha, S., Kazempoor, R., Mirzaie, A., Dakkali, M. S., Akbarzadeh, I., Meybodi, S. M., & Mirghafouri, M. (2021) · Advanced Powder Technology · doi:10.1016/j.apt.2021.10.019 · Cited by 56 · cited 1×
“However, DLS measures the hydrodynamic diameter that includes core plus any molecule attached or adsorbed on the surface, including ions and water molecules.(52,57,58) The rate of drug release depends on the composition and fluidity of the bilayer membrane.”
BackgroundSelf-citationSynergistic Anti-Staphylococcal Activity Of Niosomal Recombinant Lysostaphin-LL-37
Sadeghi, S., Bakhshandeh, H., Cohan, R. A., Peirovi, A., Ehsani, P., & Norouzian, D. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s230269 · Cited by 55 · cited 1×
“However, DLS measures the hydrodynamic diameter that includes core plus any molecule attached or adsorbed on the surface, including ions and water molecules.(52,57,58) The rate of drug release depends on the composition and fluidity of the bilayer membrane.”
BackgroundDownregulation of KLF4 and the Bcl-2/Bax ratio in advanced epithelial ovarian cancer
Yoon, O. H., & Roh, J. (2012) · Oncology Letters · doi:10.3892/ol.2012.834 · Cited by 54 · cited 1×
“These results are consistent with those of other studies that state that cancer cell progression and growth depend on the balance between pro- and antiapoptotic proteins, including the Bax and BCL-2 genes.(78,79) The expression level of p53 increased remarkably.”
ResultNiosomal delivery of simvastatin to MDA-MB-231 cancer cells
Akbarzadeh, I., Poor, A. S., Yaghmaei, S., Norouzian, D., Noorbazargan, H., Saffar, S., Cohan, R. A., & Bakhshandeh, H. (2020) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2020.1810269 · Cited by 53
Self-citationMalatesta, M., Giagnacovo, M., Costanzo, M., Conti, B., Genta, I., Dorati, R., Galimberti, V., Biggiogera, M., & Zancanaro, C. (2012) · European Journal of Histochemistry · doi:10.4081/ejh.2012.20 · Cited by 50 · cited 2×
“Polymeric nanoparticles penetrate into cancer cells, diffuse in the cytoplasm, and escape from endosomal degradation.(56,84,85) Another study revealed that nanoparticles of mesoporous silica could enter the cells and remain for a long time which is enough to allow the release of drug from formulation.”
BackgroundResultPharmacokinetic study of niosome-loaded insulin in diabetic rats.
Pardakhty, A., Moazeni, E., Varshosaz, J., Hajhashemi, V., & Najafabadi, A. R. (2011) · Europe PMC (PubMed Central) · Cited by 48
Synergistic effect of graphene oxide and zoledronic acid for osteoporosis and cancer treatment
Boran, G., Tavakoli, S., Dierking, I., Kamali, A. R., & Ege, D. (2020) · Scientific Reports · doi:10.1038/s41598-020-64760-4 · Cited by 48 · cited 1×
“Development of targeted drug delivery systems (DDSs) has received extensive attention.(12,13,14,15) The combination of medicine and nanotechnology has modified multifunctional nanocarriers that can be loaded with different drugs.”
BackgroundNaseroleslami, M., Mousavi-Niri, N., Akbarzade, I., Sharifi, M., & Aboutaleb, N. (2021) · Drug Delivery and Translational Research · doi:10.1007/s13346-021-01019-z · Cited by 47
Sadeghi, S., Ehsani, P., Cohan, R. A., Sardari, S., Akbarzadeh, I., Bakhshandeh, H., & Norouzian, D. (2020) · Pharmaceutical Chemistry Journal · doi:10.1007/s11094-020-02100-6 · Cited by 45 · cited 1×
“85) indicate that drug release is based on Fickian diffusion release.(65,66) More stability of the niosomes stored at 4 ± 2°C is possibly due to less mobility of bilayer at this temperature.”
BackgroundSelf-citationAmiri, B., Ahmadvand, H., Farhadi, A., Najmafshar, A., Chiani, M., & Norouzian, D. (2018) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2018.1451880 · Cited by 43
Self-citationMolani, S., Madadi, M., & Wilkes, W. (2018) · Omega · doi:10.1016/j.omega.2018.09.009 · Cited by 43
Dey, S. K., Mandal, B., Bhowmik, M., & Ghosh, L. K. (2009) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s1984-82502009000300025 · Cited by 41 · cited 1×
“Anticancer analysis of PEGylated niosomal formulation of artemisinin against MCF-7 cell lines showed a substitutional cytotoxicity effect for niosomal artemisinin compared with the free drug solution.(36) Furthermore, Melittin-loaded niosome revealed a significant higher apoptosis rate and inhibited cell migration, in…”
ResultEffects of Cisplatin-Loaded Niosomal Nanoparticleson BT-20 Human Breast Carcinoma Cells
Kanaani, L., Javadi, I., Ebrahimifar, M., Shahmabadi, H. E., Khiyav, A. A., & Mehrdiba, T. (2017) · Europe PMC (PubMed Central) · doi:10.22034/apjcp.2017.18.2.365 · Cited by 39
Aromatase Inhibitors: Development and Current Perspectives
Sayyad, N., Sabale, P., Umare, M. D., & Bajaj, K. K. (2022) · Indian Journal of Pharmaceutical Education and Research · doi:10.5530/ijper.56.2.51 · Cited by 39
Guo, B., Li, J. J., Ma, Y., Zhao, Y.-T., & Liu, J. (2022) · Andrology · doi:10.1111/andr.13185 · Cited by 38 · cited 1×
“5 mg/day for postmenopausal women with advanced breast cancer previously treated with antiestrogens.(9,10) Development of targeted drug delivery systems (DDSs) has received extensive attention.”
BackgroundYadavar-Nikravesh, M.-S., Ahmadi, S., Milani, A., Akbarzadeh, I., Khoobi, M., Vahabpour, R., Bolhassani, A., & Bakhshandeh, H. (2021) · Advanced Powder Technology · doi:10.1016/j.apt.2021.05.047 · Cited by 37 · cited 1×
“Furthermore, conjugation of TAT peptide on optimized PEGylated niosome improved cellular uptake into Hela cells.(87) In similar study, the internalization of doxorubicin encapsulated in nanoparticle was evaluated.”
MethodSelf-citationShirzad, M., Jamehbozorgi, S., Akbarzadeh, I., Reza, A. H., & Amini, A. (2019) · Assay and Drug Development Technologies · doi:10.1089/adt.2019.923 · Cited by 31 · cited 1×
“Moreover, these particles transfer their loaded active drug into cancer cells by selectively using tumors’ peculiar stimuli.(11,27) Functional nanoparticles and photosensitizers have been encapsulated to maintain their appropriate concentration in the tumor section.”
BackgroundSelf-citationBoer, R. D., Burris, H. A., Monnier, A., Mouridsen, H. T., O’Shaughnessy, J., Kj, M., Pritchard, K. I., Smith, I., & Yardley, D. A. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.24.18_suppl.10672 · Cited by 27
Amiri, B., & Ebrahimifar, M. (2016) · PubMed · doi:10.14456/apjcp.2016.178 · Cited by 27
Dixon, J. M., Renshaw, L., Young, O., Murray, J., Macaskill, E. J., McHugh, M., Folkerd, E. J., Cameron, D., & Dowsett, M. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.24.18_suppl.552 · Cited by 26 · cited 1×
“5 mg letrozole in comparison with those who have been treated with 1 mg of anastrozole.(73) Moreover, using 0.”
MethodChamani, E., Ebrahimi, R., Khorsandi, K., Meshkini, A., Zarban, A., & Sharifzadeh, G. (2019) · Drug and Chemical Toxicology · doi:10.1080/01480545.2019.1629588 · Cited by 20 · cited 1×
“Then 100 μL of DMSO was added to each well after removing the medium.(40) Formazan formation was quantified using a microplate reader (Biotek, USA).”
MethodKhorani, M., Bobe, G., Matthews, D. G., Magaña, A. A., Caruso, M. A., Gray, N. E., Quinn, J. F., Stevens, J. F., Soumyanath, A., & Maier, C. S. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-215084 · Cited by 20
Barbero (2014) · doi:10.1016/j · Cited by 1
Research works printed but not linked: 17
- Bray, 2018, CA, 68, 394
- Sarhadi, 2020, Trans Appl Sci, 6, 309
- Cohen, 2002, Clin Cancer Res, 8, 665
- 2020, Niosomal Delivery of Simvastatin to MDA-MB-231 Cancer Cells
- Azizi, 2015, J Chem Pharm Res, 7, 423
- Nowroozi, 2018, Iran J Pharm Sci, 17, 1
- 2020, Optimization and Characterization of Tannic Acid Loaded Niosomes for Enhanced Antibacterial and Anti-Biofilm Activities
- Dash, 2010, Acta Pol Pharm, 67, 217
- 2015, Strategies to Modify the Drug Release from Pharmaceutical Systems
- Sadeghi, 2020, Pharm Chem J, 53, 1, 10.1007/s11094-020-02100-6 · DOI
- Lawrence, 1996, STP Pharma Sci, 6, 49
- Seras-Cansell, 1996, STP Pharma Sci, 6, 12
- Pardakhty, 2011, DARU J Pharm Sci, 19, 404
- Trunet, 1993, J Clin Endocrinol Metab, 77, 319, 10.1210/jcem.77.2.8345034 · doi:10.1210/jcem.77.2.8345034 · Paper page
- Radwan, 2021, J Pharm Innov, 17, 1
- Khorani, 2022, J. Alzheimer’s Dis, 1
- Amiri, 2016, Asian Pac J Cancer Prev, 17, 3835
Cited by
Dastneshan, A., Rahiminezhad, S., Mezajin, M. N., Jevinani, H. N., Akbarzadeh, I., Abdihaji, M., Qahremani, R., Jahanbakhshi, M., Lalami, Z. A., Heydari, H., et al. (2022) · Chemical Engineering Journal · doi:10.1016/j.cej.2022.140544 · Cited by 120
Self-citationBazzazan, S., Moeinabadi‐Bidgoli, K., Lalami, Z. A., Bazzazan, S., Mehrarya, M., Yeganeh, F. E., Hejabi, F., Akbarzadeh, I., Noorbazargan, H., Jahanbakhshi, M., et al. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.104009 · Cited by 74
Self-citationCurcumin-Incorporated Biomaterials: In silico and in vitro evaluation of biological potentials
Torbat, N. A., Akbarzadeh, I., Rezaei, N., Moghaddam, Z. S., Bazzazan, S., & Mostafavi, E. (2023) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2023.215233 · Cited by 35
Self-citationBadivi, S., Kazemi, S., Eskandarisani, M., Moghaddam, N. A., Mesbahian, G., Karimifard, S., & Afzali, E. (2024) · Scientific Reports · doi:10.1038/s41598-024-68156-6 · Cited by 29
Khaledizadeh, E., Tafvizi, F., & Jafari, P. (2023) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2023.127357 · Cited by 29
Metadata
- Authors
- Ahmadi, S., Seraj, M., Chiani, M., Hosseini, S., Bazzazan, S., Akbarzadeh, I., Saffar, S., & Mostafavi, E.
- Affiliations
- Pasteur Institute of Iran (IR)
- Shahid Beheshti University (IR)
- Stanford Medicine (US)
- Corresponding author
- Mostafavi, Ebrahim
- Venue
- International Journal of Nanomedicine
- Publisher
- Informa UK Limited
- Published
- 2022-12
- Volume
- Volume 17
- Pages
- 6233-6255
- ISSN
- 1176-9114 (ISSN-L)
- 1178-2013
- PMC
- PMC9753765
- OpenAlex
- W4311260165
- Cited by
- 44
- References
- 85
- Citations by year
- 2026: 10 · 2025: 12 · 2024: 10 · 2023: 10 · 2022: 2
- FWCI
- 2.12
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Nanomedicine (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
- Funders
- Pasteur Institute of Iran
- National Institute of Biomedical Imaging and Bioengineering (T32EB009035)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advancements in Transdermal Drug Delivery
- Keywords
- letrozole, niosomes, breast cancer, controlled drug release, anticancer drug delivery, apoptosis, Bcl-2, p53, Bax, MCF-7 cells, MDA-MB-231 cells, MCF10A cells, cytotoxicity, Korsmeyer-Peppas kinetics, encapsulation efficiency, cellular uptake
- MeSH terms
- Letrozole, Breast Neoplasms, Delayed-Action Preparations, Female, Humans, Liposomes, MCF-7 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.